# Adaptimmune Therapeutics PLC: Form 8-K, filed Jun 21, 2017

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2017-06-21
- Accepted by EDGAR: Jun 21, 2017, 16:45 ET
- Period: 2017-06-21
- Accession: 0001104659-17-040686
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465917040686/a17-15503_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465917040686/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465917040686/a17-15503_18k.htm

Filed Jun 21, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-040686. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
